Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel.
The Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Catheter Cardiovasc Interv. 2020 Sep 1;96(3):556-557. doi: 10.1002/ccd.29201.
The use of VA-ECMO for patients with cardiac arrest or cardiogenic shock in the cardiac catheterization laboratory may be associated with improved survival. Clinicians should be aware of a high complication rate of this therapy. Further data is needed to best select the appropriate form of mechanical circulatory support in this clinical context.
在心脏导管室中，使用 VA-ECMO 治疗心脏骤停或心源性休克的患者可能与生存率的提高有关。临床医生应该意识到这种治疗方法的并发症发生率很高。需要进一步的数据来最好地选择在这种临床情况下适当的机械循环支持形式。
